Polymorphism A1166C of AGTR1 Gene and the State of Intrarenal Blood Flow in Patients with Essential Arterial Hypertension 1–2 Degrees

Aim: to study relationship between genetic disorders and features of intrarenal blood flow in patients with essential arterial hypertension (AH) of 1–2 degree. Materials and methods. We examined 100 patients (60 women, 40 men) aged 35 to 58 years with 1–2‑degree essential arterial hypertension (AH) and chronic kidney disease (CKD) stages I–III. Examination included triplex scanning of renal arteries on the ultrasound scanner Vivid-7 Dimension, genotyping of single-nucleotide polymorphism А1166С of the AGTR1 gene by real time polymerase chain reaction (PCR), estimation of glomerular filtration rate (GFR) using CKD-EPI formula. Patients were divided into 2 groups: group 1 included persons with I and II stage CKD (n=65, 25 men and 40 women), group 2 included patients with stages IIIA and IIIB CKD (n=35, 15 men and 20 women). Results. Among patients of group 1 prevailed genotype AA, while among group 2 patients prevailed genotype AC. Speed of blood flow in interlobar renal arteries was higher in the group 1 compared with group 2, while in the group 2 time of acceleration of blood flow was higher than in the group 1. Discussion. The data obtained are indicative of the decrease of systolic, diastolic, and averaged maximal blood flow velocity and the lengthening of acceleration time in patients with higher CKD stage. Conclusions. The presence in the genotype of patients with 1–2‑degree AH of AGTR1 1166С allele may be considered a risk factor of early development of CKD. Lowering of speed characteristics of blood flow and lengthening of the acceleration time in patients with AH can be a criterion of hypertensive nephropathy development.

1. Sethupathy P., Borel C., Gagnebin M. et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3’ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 2007;81(2):405–413.

2. Nauchno-organizacionnyj komitet proekta EHSSE-RF. EHpidemiologiya serdechno-sosudistyh zabolevanij v razlichnyh regionah Rossii (EHSSE-RF). Obosnovanie i dizajn issledovaniya. Profilakticheskaya medicina 2013;6:25–34. Russian.

3. Chazova I. E., Zhernakova Yu. V., Oshchepkova E. V. et al. Rasprostranennost’ faktorov riska razvitiya serdechno-sosudistyh zabolevanij v rossijskoj populyacii bol’nyh arterial’noj gipertoniej. Kardiologiya 2014;10:4–12. Russian.

4. Fogo A. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 2007;22:2011–2022.

5. Levey A., Greene T., Beck G. et al. for the Modification of Diet in Renal Disease Study Group. Dietary protein restriction and the progression of chronic renal disease; what have all the results of the MDRD study shown? J Am Soc Nephrol 1999;10:2426–2439.

6. Logacheva I. V., Maksimov N. I., Chernyh Yu. V. i dr. Gipertonicheskaya nefropatiya: principy diagnostiki i lecheniya. Prakticheskaya medicina 2011;1(49):42–45. Russian.

7. Dolgih V.V., Kolesnikova L.I. Patogenez ehssencial’noj arterial’noj gipertenzii u detej. Irkutsk: Izd-vo VSNC SO RAMN 1999;218s. Russian.

8. Pahomya N.S., Uryas’ev O.M., Shahanov A.V. Rol’ polimorfizmov nekotoryh genov v realizacii arterial’noj gipertenzii. Zemskij vrach 2014;3–4(24):21–24. Russian.

9. Potapov V.E., Logvinov A.K., Zaruckij S.A. et al. Osobennosti raspredeleniya odnonukleotidnyh polimorfizmov genov, associirovannyh s arterial’noj gipertenziej u bol’nyh s hronicheskoj bolezn’yu pochek. Smolenskij medicinskij al’manah 2015;1(1):138. Russian.

10. Sorokina V. N., Pavliushchik E. A., Chak T. A. et al. Assotsiatsii polimorfizma M235T gena AGT s arterial’noi gipertenziei u muzhchin. Voennaya meditsina 2016;39(2):56–59. Russian.

11. Geneticheskij pasport – osnova individual’noj i prediktivnoj mediciny pod red. V. S. Baranova. SPb.: N–L 2009;528s. Russian.

12. Serov V. V., Pal’cev M. A. Pochki i arterial’naya gipertenziya. M.: Meditsina 1993;256s. Russian.

13. Petersen L., Petersen J., Ladefoged S. et al. The pulsatility index and the resistive index in renal arteries in patients with hypertension and chronic renal failure. Nephrol Dial Transplant 1995;10(11):2060–2064.

14. Grigoryan Z.Eh., Androsova T.A., Evsev’eva M.E. et al. Indeks rezistentnosti mezhdolevyh arterij kak marker porazheniya serdechno-sosudistoj sistemy u bol’nyh s hronicheskoj bolezn’yu pochek. Nefrologiya i dializ 2009;11(2):116–123. Russian.

15. Nefrologiya: nacional’noe rukovodstvo pod red. N.A. Muhina. M.: GEOTAR-Media 2009;720s. Russian.

16. Kardiologiya: nacional’noe rukovodstvo pod red. Yu. N. Belenkova, R. G. Oganova. M.: GEOTAR-Media 2008;1232s. Russian.

17. Sauvain J., Bourscheid D., Pierrat V. et al. Duplex Doppler ultrasonography of intrarenal arteries. Normal and pathological aspects. Ann Radiol (Paris) 1991;34(4):237–247.

18. Konechnaya E.YA., Nanchikeeva M.L., Gladkaya A.A. et al. Znachenie pokazatelej vnutripochechnoj gemodinamiki u pacientov s ehssencial’noj arterial’noj gipertenziej. Ul’trazvukovaya i funkcional’naya diagnostika 2001;2:83–89. Russian.

19. Nasrullaev M.N., Vaganova G.R., Bayazitova L.I. Vozmozhnosti dopplerografii v diagnostike porazheniya pochek u bol’nyh arterial’noj gipertenziej. Prakticheskaya medicina 2011;4(52):53–55. Russian.

20. Galesic K., Brkljacic B., Sabljar-Matovinovic M. et al. Renal vascular resistance in essential hypertension: duplex-Doppler ultrasonographic evaluation. Angiology 2000;51(8):667–675.

21. Kolesnikova L.I., Dolgih V.V., Belyaeva E.V. et al. Rol’ A1166S polimorfizma gena AGTR1 v realizacii arterial’noj gipertenzii u detej s glomerulonefritom. Byulleten’ VSNC SO RAMN 2011;3(79):21–23. Russian.

22. Sethupathy P., Borel C., Gagnebin M. et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3’ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 2007;81(2):405–413.